William Ho
Net Worth
Last updated:
What is William Ho net worth?
The estimated net worth of Dr. William Ho is at least $5,493,092 as of 21 Dec 2023. He owns shares worth $160,414 as insider, has earned $2,682,678 from insider trading and has received compensation worth at least $2,650,000 in RAPT Therapeutics, Inc..
What is the salary of William Ho?
Dr. William Ho salary is $530,000 per year as Chief Medical Officer in RAPT Therapeutics, Inc..
How old is William Ho?
Dr. William Ho is 59 years old, born in 1966.
What stocks does William Ho currently own?
As insider, Dr. William Ho owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
RAPT Therapeutics, Inc. (RAPT) | Chief Medical Officer | 15,020 | $10.68 | $160,414 |
What does RAPT Therapeutics, Inc. do?
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
William Ho insider trading
RAPT Therapeutics, Inc.
Dr. William Ho has made 58 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of RAPT stock worth $54,200 on 21 Dec 2023.
The largest trade he's ever made was exercising 8,356 units of RAPT stock on 16 Nov 2020. As of 21 Dec 2023 he still owns at least 15,020 units of RAPT stock.
RAPT Therapeutics key executives
RAPT Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Brian Russell Wong M.D., Ph.D. (53) Chief Executive Officer, Pres & Director
- Dr. Dirk G. Brockstedt Ph.D. (56) Chief Scientific Officer
- Dr. William Ho (59) Chief Medical Officer